~~<i id='933A977F47'><strike id='933A977F47'><tt id='933A977F47'><pre id='933A977F47'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

author：comprehensive 2025-10-02 18:47:11 - browse：39

Ever since Medicare was given power to negotiate prices for certain medicines, the pharmaceutical industry has argued the move will end badly for patients.

Beyond complaining about price controls and unconstitutional mandates, the key message aimed at the American public has been that innovation will suffer.

This is a familiar but tiring refrain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： FDA panel signals lack of confidence in Amgen cancer drug data

entertainment

focus

entertainment

hotspot

focus

hotspot

AdobeYou’rereadingthewebeditionofSTAT’sHealthTechnewsletter,ourguidetohowtechistransformingthelifesc

WSS

Independent physicians launch a new lobbying group

AI generated plenty of interest at JPM but not a lot of trust

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Parkinson’s finding may lead to tests and, someday, treatments

Stroke deaths set to near 10 million globally by 2050

Sana to lay off nearly a third of staff, de

entertainment

entertainment

entertainment

Virginia high school admissions case could be legal follow

Stroke deaths set to near 10 million globally by 2050

Hollywood unions extend contract negotiations for actors

The tragedy of Johnson & Johnson’s Covid vaccine

State Dept. review finds Biden bears some blame for Afghanistan failures

3 questions for the future of Biden's cancer moonshot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

What to expect at HLTH 2023, the health care industry conference

23andMe had bad news about my health. I wish a person had delivered it

The surgeon had a dilemma only a Nazi medical text could resolve

focus

eGenesis tests gene

When women are denied an abortion, their children fare worse than peers

Why doctors need education on FDA device approval process

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Medicare Advantage today, explained in one chart

VC firm General Catalyst wants to buy a health system

entertainment

hotspot

focus

hotspot